170 related articles for article (PubMed ID: 33393387)
21. What to do after immune-checkpoint inhibitors failure in advanced non-small cell lung cancer: an expert opinion and review.
Agostara AG; Roazzi L; Villa F; Romano' R; Piscazzi D; Martinelli F; Ciarlo G; Oresti S; Travaglini F; Marando A; Sartore-Bianchi A; Giannetta L; Cerea G; Siena S; Pizzutilo EG; Signorelli D
Expert Rev Respir Med; 2023; 17(9):787-803. PubMed ID: 37817448
[TBL] [Abstract][Full Text] [Related]
22. Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management.
Lin MX; Zang D; Liu CG; Han X; Chen J
Front Immunol; 2024; 15():1266850. PubMed ID: 38426102
[TBL] [Abstract][Full Text] [Related]
23. [Advances in Pseudoprogression of Immune Checkpoint Inhibitors
in Non-small Cell Lung Cancer].
Tong Y; Long Y; Zhang F; Li J
Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):306-320. PubMed ID: 38769834
[TBL] [Abstract][Full Text] [Related]
24. Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy.
Luo Y; Zeng Z; Liu Y; Liu A
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189008. PubMed ID: 37913939
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of immune-related lichenoid dermatitis by Weiling decoction in a patient with non-small cell lung cancer: A case report and review of literature.
Liu Y; Tang J; Yu LY; Jiang Q
Explore (NY); 2023; 19(5):730-735. PubMed ID: 36878772
[TBL] [Abstract][Full Text] [Related]
26. Uncovering the flip side of immune checkpoint inhibitors: a comprehensive review of immune-related adverse events and predictive biomarkers.
Miao YD; Quan WX; Tang XL; Shi WW; Li Q; Li RJ; Wang JT; Gan J; Dong X; Hao L; Luan WY; Zhang F
Int J Biol Sci; 2024; 20(2):621-642. PubMed ID: 38169638
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and novel strategies of immune checkpoint inhibitor rechallenge therapy for non-small cell lung cancer: a comprehensive review.
Zhang H; Hu Y; Wu T; Chen Y; Yang B; Xie T
Front Immunol; 2023; 14():1309055. PubMed ID: 38283354
[TBL] [Abstract][Full Text] [Related]
28. Immune checkpoint inhibitor-mediated colitis in a patient with epidermoid metastatic lung cancer: new and emerging toxicities.
Álvarez-García M; Otegui L; Farrais Villalba S; Porres Cubero JC
Rev Esp Enferm Dig; 2023 Nov; 115(11):663. PubMed ID: 37539592
[TBL] [Abstract][Full Text] [Related]
29. Characterization of immunomodulatory factors and cells in bronchoalveolar lavage fluid for immune checkpoint inhibitor-related pneumonitis.
Wang PM; Zhang ZW; Zhang S; Xing Q; Zhao ZY; Lin QH; Shen LH; Xia ZL; Li FF; Zhu B
J Cancer Res Clin Oncol; 2023 Aug; 149(10):8019-8026. PubMed ID: 36944820
[TBL] [Abstract][Full Text] [Related]
30. Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.
Bonanno L; Lorenzi M; Massa D; De Nuzzo M; Angerilli V; Zingone F; Barberio B; Russi A; Girardi F; Ferro A; Dal Maso A; Frega S; Pasello G; Dei Tos AP; Coppola M; Fassan M; Savarino EV; Guarneri V
Oncologist; 2024 Jan; 29(1):e118-e130. PubMed ID: 37603442
[TBL] [Abstract][Full Text] [Related]
31. Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events.
Altan M; Li QZ; Wang Q; Vokes NI; Sheshadri A; Gao J; Zhu C; Tran HT; Gandhi S; Antonoff MB; Swisher S; Wang J; Byers LA; Abdel-Wahab N; Franco-Vega MC; Wang Y; Lee JJ; Zhang J; Heymach JV
Front Immunol; 2023; 14():1322818. PubMed ID: 38152395
[TBL] [Abstract][Full Text] [Related]
32. Case report: Brain metastasis necrosis with immune checkpoint inhibitors plus chemotherapy for advanced non-small cell lung cancer.
Niu L; Li X; Meng L; Zhang Y; Wan X; Jing D; Zhou Q; Zhou R
Front Immunol; 2022; 13():1064596. PubMed ID: 36532056
[TBL] [Abstract][Full Text] [Related]
33. Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approach.
Speranza D; Santarpia M; Luppino F; Omero F; Maiorana E; Cavaleri M; Sapuppo E; Cianci V; Pugliese A; Racanelli V; Camerino GM; Rodolico C; Silvestris N
Expert Opin Drug Saf; 2024 Jun; ():1-14. PubMed ID: 38819976
[TBL] [Abstract][Full Text] [Related]
34. Severity of COVID-19 in patients with lung cancer: evidence and challenges.
Passaro A; Bestvina C; Velez Velez M; Garassino MC; Garon E; Peters S
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737345
[TBL] [Abstract][Full Text] [Related]
35. Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept.
Aminu M; Daver N; Godoy MCB; Shroff G; Wu C; Torre-Sada LF; Goizueta A; Shannon VR; Faiz SA; Altan M; Garcia-Manero G; Kantarjian H; Ravandi-Kashani F; Kadia T; Konopleva M; DiNardo C; Pierce S; Naing A; Kim ST; Kontoyiannis DP; Khawaja F; Chung C; Wu J; Sheshadri A
Front Immunol; 2023; 14():1249511. PubMed ID: 37841255
[TBL] [Abstract][Full Text] [Related]
36. Oncology: What You May Have Missed in 2023.
Coschi CH; Dodbiba L; Guerry D
Ann Intern Med; 2024 May; 177(5_Supplement):S57-S70. PubMed ID: 38621244
[TBL] [Abstract][Full Text] [Related]
37. Is the onset of immune-related adverse events themselves a prognostic factor or a confounding factor?
Nishimura T; Fujimoto H
Lung Cancer; 2024 May; 191():107561. PubMed ID: 38582025
[No Abstract] [Full Text] [Related]
38. Immune checkpoint inhibitor-induced thyroiditis is a risk factor for acute and chronic kidney dysfunction.
Strohbehn IA; Street S; Chute D; Seethapathy H; Lee M; Seethapathy R; Drobni ZD; Rahma O; Neilan TG; Zubiri L; Reynolds K; Sise ME
Nephrol Dial Transplant; 2021 Dec; 37(1):187-189. PubMed ID: 34383953
[No Abstract] [Full Text] [Related]
39. Increased incidence of co-trimoxazole induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors.
Yiu D; Aguilar-Duran S; Edwards C; Chauhan D; Furness A; Turajlic S; Larkin J; Fearfield L; Heelan K
Br J Dermatol; 2024 May; ():. PubMed ID: 38753744
[No Abstract] [Full Text] [Related]
40. ASCO 2020 non-small lung cancer (NSCLC) personal highlights.
Horvath L; Pircher A
Memo; 2021; 14(1):66-69. PubMed ID: 33456617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
